These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 24919804)
81. Aurora Kinase A Is Upregulated in Cutaneous T-Cell Lymphoma and Represents a Potential Therapeutic Target. Humme D; Haider A; Möbs M; Mitsui H; Suárez-Fariñas M; Ohmatsu H; Isabell Geilen C; Eberle J; Krueger JG; Beyer M; Hummel M; Anagnostopoulos I; Sterry W; Assaf C J Invest Dermatol; 2015 Sep; 135(9):2292-2300. PubMed ID: 25848977 [TBL] [Abstract][Full Text] [Related]
82. Kinome profiling of chondrosarcoma reveals SRC-pathway activity and dasatinib as option for treatment. Schrage YM; Briaire-de Bruijn IH; de Miranda NF; van Oosterwijk J; Taminiau AH; van Wezel T; Hogendoorn PC; Bovée JV Cancer Res; 2009 Aug; 69(15):6216-22. PubMed ID: 19602594 [TBL] [Abstract][Full Text] [Related]
83. Global phosphotyrosine proteomics identifies PKCδ as a marker of responsiveness to Src inhibition in colorectal cancer. McKinley ET; Liu H; McDonald WH; Luo W; Zhao P; Coffey RJ; Hanks SK; Manning HC PLoS One; 2013; 8(11):e80207. PubMed ID: 24260357 [TBL] [Abstract][Full Text] [Related]
84. A phosphoproteomics approach to identify candidate kinase inhibitor pathway targets in lymphoma-like primary cell lines. Vojvodic M; Hansford LM; Morozova O; Blakely KM; Taylor P; Fathers KE; Moffat J; Marra M; Smith KM; Moran MF; Kaplan DR Curr Drug Discov Technol; 2013 Dec; 10(4):283-304. PubMed ID: 23701117 [TBL] [Abstract][Full Text] [Related]
85. In vitro studies of dasatinib, its targets and predictors of sensitivity. Jilaveanu LB; Zito CR; Aziz SA; Chakraborty A; Davies MA; Camp RL; Rimm DL; Dudek A; Sznol M; Kluger HM Pigment Cell Melanoma Res; 2011 Apr; 24(2):386-9. PubMed ID: 21320292 [No Abstract] [Full Text] [Related]
86. Cabozantinib and dastinib exert anti-tumor activity in alveolar soft part sarcoma. Mukaihara K; Tanabe Y; Kubota D; Akaike K; Hayashi T; Mogushi K; Hosoya M; Sato S; Kobayashi E; Okubo T; Kim Y; Kohsaka S; Saito T; Kaneko K; Suehara Y PLoS One; 2017; 12(9):e0185321. PubMed ID: 28945796 [TBL] [Abstract][Full Text] [Related]
87. Targeting the LYN/HS1 signaling axis in chronic lymphocytic leukemia. ten Hacken E; Scielzo C; Bertilaccio MT; Scarfò L; Apollonio B; Barbaglio F; Stamatopoulos K; Ponzoni M; Ghia P; Caligaris-Cappio F Blood; 2013 Mar; 121(12):2264-73. PubMed ID: 23325840 [TBL] [Abstract][Full Text] [Related]
88. Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor. Wolfe JT; Chooback L; Finn DT; Jaworsky C; Rook AH; Lessin SR J Clin Oncol; 1995 Jul; 13(7):1751-7. PubMed ID: 7602365 [TBL] [Abstract][Full Text] [Related]
89. Preclinical Studies Support Combined Inhibition of BET Family Proteins and Histone Deacetylases as Epigenetic Therapy for Cutaneous T-Cell Lymphoma. Zhao L; Okhovat JP; Hong EK; Kim YH; Wood GS Neoplasia; 2019 Jan; 21(1):82-92. PubMed ID: 30529073 [TBL] [Abstract][Full Text] [Related]
90. The Src/ABL kinase inhibitor dasatinib (BMS-354825) inhibits function of normal human T-lymphocytes in vitro. Blake S; Hughes TP; Mayrhofer G; Lyons AB Clin Immunol; 2008 Jun; 127(3):330-9. PubMed ID: 18395492 [TBL] [Abstract][Full Text] [Related]
91. Polo-like kinase 1 (Plk1) is expressed by cutaneous T-cell lymphomas (CTCLs), and its downregulation promotes cell cycle arrest and apoptosis. Nihal M; Stutz N; Schmit T; Ahmad N; Wood GS Cell Cycle; 2011 Apr; 10(8):1303-11. PubMed ID: 21436619 [TBL] [Abstract][Full Text] [Related]
92. Flow cytometric determination of Src phosphorylation in pediatric patients treated with dasatinib. Guerrouahen BS; Wieder E; Blanchard EG; Lee FY; Aplenc R; Corey SJ Pediatr Blood Cancer; 2009 Dec; 53(6):1132-5. PubMed ID: 19484755 [TBL] [Abstract][Full Text] [Related]
94. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma. Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151 [TBL] [Abstract][Full Text] [Related]
95. Desmoplastic small round cell tumor: from genomics to targets, potential paths to future therapeutics. Magrath JW; Espinosa-Cotton M; Flinchum DA; Sampath SS; Cheung NK; Lee SB Front Cell Dev Biol; 2024; 12():1442488. PubMed ID: 39139449 [TBL] [Abstract][Full Text] [Related]
96. Transcriptomic analysis identifies B-lymphocyte kinase as a therapeutic target for desmoplastic small round cell tumor cancer stem cell-like cells. Magrath JW; Flinchum DA; Hartono AB; Sampath SS; O'Grady TM; Baddoo M; Haoyang L; Xu X; Flemington EK; Lee SB Oncogenesis; 2024 Jan; 13(1):2. PubMed ID: 38177125 [TBL] [Abstract][Full Text] [Related]
97. Tyrosine kinases in nodal peripheral T-cell lymphomas. Piccaluga PP; Cascianelli C; Inghirami G Front Oncol; 2023; 13():1099943. PubMed ID: 36845713 [TBL] [Abstract][Full Text] [Related]
98. The survival rate of laryngeal squamous cell carcinoma: impact of IL1RAP rs4624606, IL1RL1 rs1041973, IL-6 rs1800795, BLK rs13277113, and TIMP3 rs9621532 single nucleotide polymorphisms. Pasvenskaite A; Liutkeviciene R; Gedvilaite G; Vilkeviciute A; Liutkevicius V; Uloza V Discov Oncol; 2023 Jan; 14(1):8. PubMed ID: 36682035 [TBL] [Abstract][Full Text] [Related]
99. Biological Effects of Human Exposure to Environmental Cadmium. Peana M; Pelucelli A; Chasapis CT; Perlepes SP; Bekiari V; Medici S; Zoroddu MA Biomolecules; 2022 Dec; 13(1):. PubMed ID: 36671421 [TBL] [Abstract][Full Text] [Related]
100. Prognostic significance of BLK expression in R-CHOP treated diffuse large B-cell lymphoma. Choi S; Lee YJ; Choi Y; Kim M; Kim HJ; Kim JE; Oh S; Chae SW; Cha HJ; Jo JC J Pathol Transl Med; 2022 Sep; 56(5):281-288. PubMed ID: 36128864 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]